Advertisement

Zydus Lifesciences Strengthens Urology Portfolio with USFDA Approval of Methenamine Hippurate Tablets


Updated: March 12, 2025 12:59

Image Source: Medical Dialogues

Stay Ahead – Explore Now! Dividends & Delivery—CONCOR’s ₹21.54B Q1 Revenue Signals Strong Ride Ahead

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement